AbbVie Innovation Center Opens at the University of Illinois-Urbana Research Park

CHAMPAIGN, Ill.--The University of Illinois today announced that AbbVie (ABBV), a global research-based biopharmaceutical company based in North Chicago, IL, has opened the AbbVie Innovation Center on campus at the University of Illinois Research Park in Urbana-Champaign.

The AbbVie Innovation Center plans to employ more than 18 students, from undergraduate to graduate level, on a part-time basis throughout the year. Eight students have started working on several AbbVie Research & Development Information Technology projects, which is the initial focus of work in the AbbVie Innovation Center. AbbVie is currently hiring for several open positions.

"At AbbVie, we know that advancing science requires strong collaboration and different ways of working. Establishing this innovative and collaborative work center at a world-class research university offers us access to top students and faculty who can help us explore new ideas," said Mike Carlin, Vice President, R&D Information Technology, AbbVie. "The AbbVie Innovation Center is a great example of how AbbVie is partnering in unique ways to find new solutions that will have an impact for patients."

Students will work on real-world projects ranging from utilizing visualization software which can help AbbVie scientists see clinical trial research data in new ways, to harnessing the power of reporting tools which helps AbbVie medical teams identify additional areas of research, to using informatics, text mining and other analytics software to uncover connections in medical research – all of which can lead to discoveries that will improve patient care.

While students will gain real-world professional experience by working directly with AbbVie project managers, an AbbVie Site Manager will manage the students and serve as liaison between the AbbVie Innovation Center and the University of Illinois.

"The AbbVie Innovation Center will give our students the opportunity to be at the forefront of information technologies for leading-edge therapies that can make a difference in people's lives," said Chancellor Phyllis Wise. "Such real-world experiences are examples of the transformative educational opportunities at Illinois that grow from our leadership in engineering, big data, and biomedical sciences."

The Research Park, located on the campus of the University of Illinois in Champaign, provides an opportunity for technology-based businesses to collaborate with students and faculty. The University of Illinois at Urbana-Champaign's College of Engineering is among the highest ranked in the nation, and is a highly sought after partner for pursuing the integration of engineering, computing, and medicine.

About the Research Park at the University of Illinois

Since its founding in 1867, the University of Illinois at Urbana-Champaign has earned a reputation as a world-class leader in research, teaching, and public engagement. The Research Park at the University of Illinois at Urbana-Champaign provides an environment where technology-based businesses can work with faculty and students at Illinois to take advantage of opportunities for collaborative research and easy access to University labs, equipment, and services. The Research Park is home to more than 90 companies and growing, employing over 1,500 people in high-technology careers. At any given time, more than 450 student interns are gaining valuable work experience while making real contributions to internal corporate R&D and product development programs. Publicly-traded and/or Fortune 500 firms in the Research Park include: AB InBev, ADM, Abbott Laboratories, Caterpillar, Deere & Company, Dow Chemical, Littelfuse, Raytheon, Riverbed, Citrix, State Farm, and Yahoo.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit Follow @abbvieon Twitter or view careers on our Facebook or LinkedIn page.

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.